1 to 10 of 81 literature results

• Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial.

  BACKGROUND: Rosiglitazone is an insulin sensitiser used in combination with metformin, a sulfonylurea, or both, for lowering blood glucose in people w…

  Authors: Philip D Home, Stuart J Pocock, Henning Beck-Nielsen, Paula S Curtis, Ramon Gomis, Markolf Hanefeld, Nigel P Jones, Michel Komajda, John J V McMurray, RECORD Study Team

  Source: Lancet. 2009 Jun 20

  View Full Text

• Identification of the oxidized low-density lipoprotein scavenger receptor CD36 in plasma: a novel marker of insulin resistance.

  BACKGROUND: Macrophage CD36 scavenges oxidized low-density lipoprotein, leading to foam cell formation, and appears to be a key proatherogenic molecul…

  Authors: Aase Handberg, Klaus Levin, Kurt Højlund, Henning Beck-Nielsen

  Source: Circulation. 2006 Sep 12

  View Full Text

• Microalbuminuria, preeclampsia, and preterm delivery in pregnant women with type 1 diabetes: results from a nationwide Danish study.

  OBJECTIVE: To study the association between microalbuminuria and development of preeclampsia and preterm delivery in pregnant women with type 1 diabet…

  Authors: Dorte M Jensen, Peter Damm, Per Ovesen, Lars Mølsted-Pedersen, Henning Beck-Nielsen, Jes G Westergaard, Margrethe Moeller, Elisabeth R Mathiesen

  Source: Diabetes care. 2010 Jan

  View Full Text

• Increased risk of type 2 diabetes in elderly twins.

  OBJECTIVE: Genetic susceptibility, low birth weight (LBW), and aging are key etiological factors in the development of type 2 diabetes. LBW is common …

  Authors: Pernille Poulsen, Louise G Grunnet, Kasper Pilgaard, Heidi Storgaard, Amra Alibegovic, Mette P Sonne, Bendix Carstensen, Henning Beck-Nielsen, Allan Vaag

  Source: Diabetes. 2009 Jun

  View Free Full Text

• Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes.

  OBJECTIVE: To study the association between peri-conceptional A1C and serious adverse pregnancy outcome (congenital malformations and perinatal mortal…

  Authors: Dorte M Jensen, Lars Korsholm, Per Ovesen, Henning Beck-Nielsen, Lars Moelsted-Pedersen, Jes G Westergaard, Margrethe Moeller, Peter Damm

  Source: Diabetes care. 2009 Jun

  View Free Full Text

• Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment.

  OBJECTIVE: We investigated the relation between soluble CD36 (sCD36), risk markers of atherosclerosis and body composition, and glucose and lipid meta…

  Authors: Dorte Glintborg, Kurt Højlund, Marianne Andersen, Jan Erik Henriksen, Henning Beck-Nielsen, Aase Handberg

  Source: Diabetes care. 2008 Feb

  View Full Text

• Rising prevalence of diabetes: evidence from a Danish pharmaco-epidemiological database.

  The prevalence of diabetes has increased worldwide. We have undertaken an epidemiological analysis of drug-treated diabetes in a well defined communit…

  Authors: Henrik Støvring, Morten Andersen, Henning Beck-Nielsen, Anders Green, Werner Vach

  Source: Lancet. 2003 Aug 16

  View Full Text

• Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial.

  AIMS: Thiazolidinediones are insulin sensitizers, and are associated with fluid retention and increased risk of heart failure (HF) in people with type…

  Authors: Michel Komajda, John J V McMurray, Henning Beck-Nielsen, Ramon Gomis, Markolf Hanefeld, Stuart J Pocock, Paula S Curtis, Nigel P Jones, Philip D Home

  Source: European heart journal. 2010 Apr

  View Full Text

• The SNARE protein SNAP23 and the SNARE-interacting protein Munc18c in human skeletal muscle are implicated in insulin resistance/type 2 diabetes.

  OBJECTIVE: Our previous studies suggest that the SNARE protein synaptosomal-associated protein of 23 kDa (SNAP23) is involved in the link between incr…

  Authors: Pontus Boström, Linda Andersson, Birgitte Vind, Liliana Håversen, Mikael Rutberg, Ylva Wickström, Erik Larsson, Per-Anders Jansson, Maria K Svensson, Richard Brånemark,…

  Source: Diabetes. 2010 Aug

  View Full Text

• Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.

  OBJECTIVE: Insulin resistance in skeletal muscle is a major risk factor for type 2 diabetes in women with polycystic ovary syndrome (PCOS). However, t…

  Authors: Kurt Højlund, Dorte Glintborg, Nicoline R Andersen, Jesper B Birk, Jonas T Treebak, Christian Frøsig, Henning Beck-Nielsen, Jørgen F P Wojtaszewski

  Source: Diabetes. 2008 Feb

  View Full Text